Hyponatraemia


Background


Clinical

Symptoms:

  • Always present when osmolality less than 240 meq
  • Rate of fall important
  • Increased severity in children and women of child bearing age
  • > 125 mmols/l usually asymptomatic
  • 125 to 115 mmols/l subtle changes in mental status, eg confusion
  • < 115 mmols/l stupor ,neuromuscular hyper-excitability, convulsions, coma, and initial improvement may be followed by delayed neurological symptoms
  • Central pontime myelinolysis is uncommon

Causes:

  • Factitious (hyper-proteinaemia / lipidaemia / glycaemia and mannitol
  • Water retention (renal, hepatic and cardiac failure, hypothyroidism)
  • SIADH
  • Polydipsia
  • Salt loss (adrenal cortical insufficiency, diurectics, fluid therapy, post-trauma and stress)
  • Cerebral salt wasting syndrome


SIADH

Criteria

  • hyponatraemia
  • hypotonicity
  • urinary sodium > 20 mmol/l
  • urine osmolality > plasma osmolality
  • normovolaemia
  • elevated serum ADH
  • correction with water restriction
  • failure to drop urinary osmolality with fluid challenge
  • absence of renal, hepatic, cardiac, thyroid disease
  • absence of drugs that effect renal water handling

Causes of SIADH

  • tumour
  • neurological
  • pulmonary
  • drugs (tolbutamide, carbamazepine, fluphenazine, anti-depressants, barbiturates

Treatment of SIADH

  • treat underlying cause
  • fluid restrict to 500 - 1000 mls/day
  • IV normal saline
  • 3% NaCl through central line if rapid correction required
  • ledermycin (tetracycline with ADH antagonist properties)

Management hyponatraemia

Acute hyponatraemia treated with IV normal saline (particularly in volume depleted)

Chronic hyponatraemia should be corrected slowly

If SIADH suspected then